BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,448,000 | +3.1% | 27,406 | +19.5% | 0.00% | 0.0% |
| Q2 2020 | $1,405,000 | -4.8% | 22,931 | -12.1% | 0.00% | 0.0% |
| Q1 2020 | $1,476,000 | -12.6% | 26,094 | -12.0% | 0.00% | 0.0% |
| Q4 2019 | $1,689,000 | -34.2% | 29,661 | -38.2% | 0.00% | 0.0% |
| Q3 2019 | $2,568,000 | -39.7% | 47,979 | -32.7% | 0.00% | -50.0% |
| Q2 2019 | $4,256,000 | – | 71,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 36,000 | $2,244,000 | 2.71% |
| JW Asset Management, LLC | 73,649 | $4,591,000 | 2.36% |
| THB ASSET MANAGEMENT | 87,491 | $5,453,000 | 0.79% |
| RICE HALL JAMES & ASSOCIATES, LLC | 315,972 | $19,695,000 | 0.63% |
| EAM Global Investors LLC | 22,789 | $1,420,000 | 0.63% |
| Elk Creek Partners, LLC | 73,936 | $4,608,000 | 0.33% |
| Matarin Capital Management, LLC | 69,964 | $4,361,000 | 0.32% |
| EAM Investors, LLC | 17,696 | $1,103,000 | 0.27% |
| CADENCE CAPITAL MANAGEMENT LLC | 37,196 | $2,318,000 | 0.21% |
| Cavalier Investments, LLC | 7,800 | $486,000 | 0.20% |